Tempest Therapeutics Faces Setback on Governance Reforms
at www.tipranks.com (Tue, 20-Oct 4:30 PM)
Tempest Therapeutics Adds Veteran Executive to Board
at www.tipranks.com (Mon, 19-Oct 4:34 PM)
Tempest secures an exclusive option for a clinical-stage CD7-targeted in vivo CAR-T platform, adding a second delivery approach alongside its LNP program
Market Chameleon (Wed, 16-Sep 9:52 AM)
